uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer

NCT02805608 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Urinary Bladder Neoplasms

Interventions

DRUG: Injection of 68Ga-NOTA-AE105
DRUG: Injection of 18F-FDG
DEVICE: Positron Emission Tomography and CT
DEVICE: Positron Emission Tomography and MRI

Sponsor

Rigshospitalet, Denmark